Eric J Ende's Net Worth
$4.9 Million
Who is Eric J Ende?
Eric J Ende has an estimated net worth of $4.9 Million. This is based on reported shares across multiple companies, which include GENZYME CORP, Matinas BioPharma Holdings, Inc., AVADEL PHARMACEUTICALS PLC, NeuBase Therapeutics, Inc., and PROGENICS PHARMACEUTICALS INC.
SEC CIK
Eric J Ende's CIK is 0001494386
Past Insider Trading and Trends
2019 was Eric J Ende's most active year for acquiring shares with 12 total transactions. Eric J Ende's most active month to acquire stocks was the month of July. 2011 was Eric J Ende's most active year for disposing of shares, totalling 3 transactions. Eric J Ende's most active month to dispose stocks was the month of March. 2017 saw Eric J Ende paying a total of $876,000.00 for 562,201 shares, this is the most they've acquired in one year. In 2011 Eric J Ende cashed out on 11,875 shares for a total of $542,830.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GENZYME CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$74.00 | -$175,750.00 |
0
|
Apr 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Matinas BioPharma Holdings, Inc. (MTNB) Snapshot price: $3.45
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 4
| +24.98% | 28.8K |
—
|
—
| 144.09K |
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 4
| +3.22% | 3.6K |
—
|
—
| 115.29K |
Jun 23
| |||
Form 4
| +2.20% | 2.4K |
—
|
—
| 111.69K |
Jun 21 - Nov 1
| |||
Form 4
| +22.40% | 20K |
$0.66 | $13,200.00 | 109.29K |
Aug 20
| |||
Form 4
| +28.86% | 20K |
$0.68 | $13,650.00 | 89.29K |
Aug 19
| |||
Form 4/A
|
∞
| 12.2K |
—
|
—
| 12.2K |
Apr 3
| |||
Form 4
| +35.71% | 15.02K |
—
|
—
| 57.09K |
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 4
| +30.03% | 9.71K |
—
|
—
| 42.07K |
Oct 1
| |||
Form 4
| +175.12% | 20.59K |
—
|
—
| 32.35K |
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
∞
| 11.76K |
—
|
—
| 11.76K |
Mar 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVADEL PHARMACEUTICALS PLC (AVDL) Snapshot price: $14.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +6.55% | 11K |
—
|
—
| 178.9K |
Jul 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
| +8.39% | 13K |
$13.93 | $181,100.40 | 167.9K |
May 18
| |||
Form 4
| +14.83% | 20K |
$7.80 | $156,050.00 | 154.9K |
Nov 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 3
| |||
Form 4
| +35.04% | 35K |
$2.23 | $77,890.00 | 134.9K |
May 31 - Jun 1
| |||
Form 4
| +17.67% | 15K |
$2.45 | $36,747.00 | 99.9K |
May 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 3
| |||
Form 4
| +25.04% | 17K |
$5.79 | $98,375.60 | 84.9K |
Sep 17
| |||
Form 4
| +7.95% | 5K |
$7.79 | $38,928.00 | 67.9K |
Aug 13
| |||
Form 4
| +31.32% | 15K |
$7.76 | $116,355.00 | 62.9K |
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 7
| |||
Form 4
| +26.39% | 10K |
$5.97 | $59,700.00 | 47.9K |
Dec 4
| |||
Form 4
| +35.84% | 10K |
$4.98 | $49,762.00 | 37.9K |
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 7
| |||
Form 4
|
∞
| 27.9K |
—
|
—
| 27.9K |
Jan 31 - May 22
| |||
Form 4
|
∞
| 27.9K |
—
|
—
| 27.9K |
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NeuBase Therapeutics, Inc. (NBSE) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PROGENICS PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||